New Zealand eases prescription requirement for cannabis-based Sativex

  • New Zealand eases prescription requirement for cannabis-based medicine Sativex
  • Medical practitioners registered with the Medical Council of New Zealand are able to prescribe Sativex for a patient under their care, according to the notice in the Gazette.
  • A medical practitioner registered with the Medical Council of New Zealand.
  • Sativex, produced by United Kingdom-based GW Pharmaceuticals, is distributed by Emerge Health in Australia and New Zealand.

Read full article: mjbizdaily.com